Acadian Asset Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,026
| Closed | -$146K | – | 1800 |
|
|
2025
Q1 | $146K | Sell |
3,026
-2,863
| -49% | -$138K | ﹤0.01% | 1300 |
|
|
2024
Q4 | $226K | Buy |
5,889
+3,502
| +147% | +$134K | ﹤0.01% | 1243 |
|
|
2024
Q3 | $106K | Buy |
+2,387
| New | +$106K | ﹤0.01% | 1578 |
|
|
2023
Q1 | – | Sell |
-9,199
| Closed | -$100K | – | 1922 |
|
|
2022
Q4 | $100K | Sell |
9,199
-128,001
| -93% | -$1.39M | ﹤0.01% | 1431 |
|
|
2022
Q3 | $1.16M | Buy |
+137,200
| New | +$1.16M | 0.01% | 765 |
|
|
2021
Q1 | – | Sell |
-15,349
| Closed | -$309K | – | 2273 |
|
|
2020
Q4 | $309K | Buy |
+15,349
| New | +$309K | ﹤0.01% | 1396 |
|
|
2019
Q4 | – | Sell |
-156,961
| Closed | -$1.89M | – | 2023 |
|
|
2019
Q3 | $1.89M | Buy |
+156,961
| New | +$1.89M | 0.01% | 698 |
|
|
2019
Q2 | – | Sell |
-242,862
| Closed | -$3.05M | – | 1999 |
|
|
2019
Q1 | $3.05M | Sell |
242,862
-13,358
| -5% | -$168K | 0.01% | 570 |
|
|
2018
Q4 | $1.73M | Buy |
256,220
+6,516
| +3% | +$43.9K | 0.01% | 601 |
|
|
2018
Q3 | $2.57M | Buy |
249,704
+15,874
| +7% | +$163K | 0.01% | 515 |
|
|
2018
Q2 | $1.57M | Buy |
233,830
+175,849
| +303% | +$1.18M | 0.01% | 622 |
|
|
2018
Q1 | $498K | Buy |
57,981
+48,522
| +513% | +$417K | ﹤0.01% | 864 |
|
|
2017
Q4 | $197K | Buy |
+9,459
| New | +$197K | ﹤0.01% | 960 |
|